Curr Protoc, 2023 · DOI: 10.1002/cpz1.743 · Published: April 1, 2023
Central nervous system glial cells play a role in neurocognitive and neurodegenerative diseases like Alzheimer’s and Parkinson’s. Similar glial responses are important in peripheral nervous system diseases, such as neuropathic pain and diabetic neuropathy. This paper describes a method for preparing mixed glial cells from adult mouse spinal cord for in vitro study. The described protocol involves enzymatically dissociating spinal cord tissue. The adult mixed glial cells are ready for use 12-14 days after culture establishment. This method can be used on spinal cord tissues from adult rats and potentially other species. Mixed glial cultures can be prepared from different animal strains or after in vivo manipulations. They are suitable for studying diseases involving spinal cord pathological changes like amyotrophic lateral sclerosis and multiple sclerosis, as well as toxin-induced changes.
Using adult spinal cord glial cells can provide more relevant data for understanding adult-onset neurological diseases compared to using neonatal cells or cell lines.
The protocol can be used to assess the effects of various toxins, chemicals, and drugs on adult spinal cord glial cells, aiding in toxicological research.
The method’s flexibility allows for the use of genetically modified animals or animals that have undergone in vivo treatment, facilitating the study of personalized medicine approaches for spinal cord disorders.